Omeprazole formulation

Details Omeprazole formulation Omeprazole formulation

1999-06-18

2000-06-20

Williamson, Michael A.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424479, 424475, 424474, A61K 934

Patent

active

060775416

ABSTRACT:
A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of:

REFERENCES:
patent: 4045563 (1977-08-01), Berntsson et al.
patent: 4045564 (1977-08-01), Berntsson et al.
patent: 4182766 (1980-01-01), Krasso et al.
patent: 4255431 (1981-03-01), Junggren et al.
patent: 4337257 (1982-06-01), Junggren et al.
patent: 4359465 (1982-11-01), Ruwart
patent: 4432966 (1984-02-01), Zeitoun et al.
patent: 4508905 (1985-04-01), Junggren et al.
patent: 4544750 (1985-10-01), Brandstrom et al.
patent: 4620008 (1986-10-01), Brandstrom et al.
patent: 4636499 (1987-01-01), Brandstrom et al.
patent: 4686230 (1987-08-01), Rainer et al.
patent: 4738974 (1988-04-01), Brandstrom
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 4840799 (1989-06-01), Appeigren et al.
patent: 4853230 (1989-08-01), Lovgren et al.
patent: 5045321 (1991-09-01), Makino et al.
patent: 5093132 (1992-03-01), Makino et al.
patent: 5093342 (1992-03-01), Tomoi et al.
patent: 5178867 (1993-01-01), Guittard et al.
patent: 5204118 (1993-04-01), Goldman et al.
patent: 5219870 (1993-06-01), Kim
patent: 5232706 (1993-08-01), Polomo Coll
patent: 5244670 (1993-09-01), Upson et al.
patent: 5288506 (1994-02-01), Spickett et al.
patent: 5304540 (1994-04-01), Blackburn et al.
patent: 5330982 (1994-07-01), Tyers
patent: 5352688 (1994-10-01), Kaminski
patent: 5362424 (1994-11-01), Lee et al.
patent: 5385739 (1995-01-01), Debregeas et al.
patent: 5389664 (1995-02-01), Baile et al.
patent: 5399700 (1995-03-01), Min et al.
patent: 5417980 (1995-05-01), Goldman et al.
patent: 5433959 (1995-07-01), Makino et al.
patent: 5508041 (1996-04-01), Lee et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5599794 (1997-02-01), Eek et al.
patent: 5620964 (1997-04-01), Roth et al.
patent: 5622717 (1997-04-01), Fuisz
patent: 5637320 (1997-06-01), Bourke et al.
patent: 5639478 (1997-06-01), Makino et al.
patent: 5693818 (1997-12-01), Von Unge
patent: 5714504 (1998-02-01), Lindberg et al.
patent: 5753265 (1998-05-01), Bergstrand et al.
L. Olbe, S.E. et al., Present Situation and Future Prospects of Medical Treatment., Gastrins and the Vagus, Academic Press p. 245-250, 1979.
M.R. Thompson, The Unnatural History of Drug-Associated Gastric Ulcers., Gut, vol. 22, No. 10, Oct. 1981.
Eric Fellenius et al., Substituted Benzimidazoles Inhibit Gastric Acid Secretion by Blocking (H+ + K+) ATPase., Nature, vol. 290, Mar. 12, 1981.
Tore Lind, et al., Effect of Omeprazole--A Gastric Proton Pump Inhibitor on Pentagastrin Stimulated Acid Secretion in Man., Gut, vol. 24 p. 270-276, 1983.
K-Fr Sewin et al., Effect of Substituted Benzimidazoles on Acid Secretion in Isolated and Enriched Guinea Pig Parietal Cells., Gut, vol. 24 p. 557-560, Jun. 1983.
Haken Larsson et al., Inhibition of Gastric Acid Secretion by Omeprazole in the Dog and the Rat., Gastroenterology, vol. 85 p. 900-907, Oct. 1983.
Walter London et al., Dose-Response Study of Omeprazole on Meal Stimulated Gastric Acid Secretion and Gastrin Release., Gastroenterology, vol. 85 p. 1373-1378, Dec. 1983.
Stanislaw J., Effects of Omeprazole, a Substituted Benzimidazole, on Gastrointestinal Secretions, Serum Gastrin and Gastric Mucosal Blood Flow on Dogs., Gastroenterology, vol. 86, p. 71-77, Jan. 1984.
D.A. Henry et al., Omeprazole: Effects on Oxidative Drug Metabolism., British Journal of Clinical Pharmocology, vol. 18, p. 195-200, Aug. 1984.
B.K. Sharma et al. Optimal Dose of Omeprazole for Maximal 24 Hour Decrease of Intragastric Acidity. Gut, vol. 25 p. 957-964, Sep. 1984.
H.P.M. Festen et al., Effect of Oral Omeprazole on Serum Gastrin and Serum Pepsinogen I Levels. Gastroenterolgy, vol. 87 p. 1030-1034, Nov. 1984.
Peter Prichard et al., Omeprazole: A study of its Inhibition of Gastric pH and Oral Pharmacokinetics After Morning or Evening Dosages, Gastroenterology, vol. 88, Jan. 1985.
K.O. Borg and L. Olbe, Omeprazole--A Study fo Preclinical Data, Gastroenterology, p. 15-22, 37-51, 71-77, 79-93,105-120, Jun. 1985.
50th Ed. Physician's Desk Reference p. 529-531.
K.O. Borg, L. Olbe Proceedings of the First International Symposium on Omeprazole, Supplement to the Scandinavian Journal of Gastroenterology, pp. 11-17, 31-38, 54-56, 59-60, 75-76, 77-78, 89-91, 92-98, 99-104, 105-135, 179, 182-183, 187-195, 1996.

Affiliated with

Also associated with

Rating

Omeprazole formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Omeprazole formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omeprazole formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1850081